We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+40.12%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$2.98B
AUM Growth
+$1.06B
Cap. Flow
+$658M
Cap. Flow %
22.1%
Top 10 Hldgs %
14.47%
Holding
1,103
New
423
Increased
157
Reduced
131
Closed
302

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$22.3M
2
MPC icon
Marathon Petroleum
MPC
+$9.07M
3
AXTA icon
Axalta
AXTA
+$6.53M
4
TRGP icon
Targa Resources
TRGP
+$5.63M
5
PLNT icon
Planet Fitness
PLNT
+$5.39M

Sector Composition

Rank Sector Weight
1 Healthcare 5.74%
2 Consumer Discretionary 2.23%
3 Technology 2%
4 Financials 1.03%
5 Energy 0.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPO icon
251
CALL
Enpro
NPO
$6.63B
$3.34M 0.11%
+50,000
New +$3.32M
NPO icon
252
PUT
Enpro
NPO
$6.63B
$3.34M 0.11%
+50,000
New +$3.32M
TIF
253
CALL
DELISTED
Tiffany & Co.
TIF
$3.34M 0.11%
+25,000
New +$2.95M
CCK icon
254
Crown Holdings
CCK
$12.8B
$3.33M 0.11%
45,900
+35,900
+359% +$2.56M
ECHO
255
CALL
EchoStar
ECHO
$24.4B
$3.29M 0.11%
+76,000
New +$3.05M
KSS icon
256
Kohl's
KSS
$2.17B
$3.28M 0.11%
+64,300
New +$3.27M
TFC icon
257
CALL
Truist Financial
TFC
$63.3B
$3.25M 0.11%
+57,800
New +$3.13M
LH icon
258
Labcorp
LH
$25B
$3.23M 0.11%
+22,232
New +$3.21M
APLS
259
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$3.23M 0.11%
+105,400
New +$2.92M
DXC icon
260
DXC Technology
DXC
$1.82B
$3.2M 0.11%
+85,100
New +$2.78M
SO icon
261
CALL
Southern Company
SO
$109B
$3.19M 0.11%
+50,000
New +$3.1M
SO icon
262
PUT
Southern Company
SO
$109B
$3.19M 0.11%
+50,000
New +$3.1M
XLRN
263
PUT
DELISTED
Acceleron Pharma
XLRN
$3.18M 0.11%
60,000
MTZ icon
264
CALL
MasTec
MTZ
$21.1B
$3.14M 0.11%
+49,000
New +$3.23M
MRTX
265
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.13M 0.11%
+24,300
New +$2.34M
RESI
266
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$3.12M 0.1%
+253,000
New +$3M
MDT icon
267
Medtronic
MDT
$109B
$3.12M 0.1%
27,500
-2,500
-8% -$274K
DCPH
268
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3.11M 0.1%
50,000
+30,000
+150% +$1.43M
CSTM icon
269
CALL
Constellium
CSTM
$3.76B
$3.08M 0.1%
+230,000
New +$3.17M
INCY icon
270
PUT
Incyte
INCY
$24.2B
$3.06M 0.1%
+35,000
New +$2.99M
STLA icon
271
CALL
Stellantis
STLA
$21.7B
$3.05M 0.1%
207,700
VTRS icon
272
CALL
Viatris
VTRS
$20.4B
$3.01M 0.1%
150,000
CPRI icon
273
Capri Holdings
CPRI
$1.83B
$3.01M 0.1%
+78,900
New +$2.72M
STAA icon
274
CALL
STAAR Surgical
STAA
$1.21B
$2.99M 0.1%
85,000
-204,000
-71% -$6.73M
STAA icon
275
PUT
STAAR Surgical
STAA
$1.21B
$2.99M 0.1%
85,000
+35,000
+70% +$1.15M

Similar funds

Caption Management's Q4 2019 Portfolio in Review

As of Q4 2019, Caption Management held 1,103 positions worth $2.98B, up 55% from $1.92B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Caption Management deployed $658M of net new capital in Q4 2019, opening 423 new positions and adding to 157 existing holdings. Its largest new stake was Tradeweb Markets: 256,000 shares worth $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 5.7% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $9.07M trimmed.

  • Caption Management's largest Q4 2019 buy was Tradeweb Markets: 256,000 shares worth $11.9M.
  • Caption Management added most to uniQure in Q4 2019, an estimated $16.9M increase.
  • Caption Management's biggest Q4 2019 reduction was Marathon Petroleum, cutting an estimated $9.07M.
  • Caption Management fully exited PayPal in Q4 2019, selling an estimated $22.3M.
  • Caption Management's ten largest holdings make up 14% of its $2.98B portfolio in Q4 2019.
  • Caption Management opened 423 new positions and closed 302 in Q4 2019.
  • Caption Management's portfolio value rose 55% quarter-over-quarter to $2.98B.

Based on Caption Management's 13F filing for Q4 2019, filed 13 Feb 2020.